Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$352K Sell
971
-25
-3% -$8.56K 0.07% 174
2026
Q1
$350K Sell
996
-638
-39% -$227K 0.07% 172
2025
Q4
$535K Buy
+1,634
New +$518K 0.11% 144
2023
Q4
Sell
-509
Closed -$136K 250
2023
Q3
$136K Buy
+509
New +$127K 0.03% 253
2014
Q2
Sell
-5,350
Closed -$660K 101
2014
Q1
$660K Hold
5,350
0.28% 62
2013
Q4
$610K Hold
5,350
0.26% 63
2013
Q3
$599K Hold
5,350
0.26% 64
2013
Q2
$528K Buy
+5,350
New +$555K 0.23% 65

Other funds holding AMGN

HeadInvest LLC's AMGN Position: Q2 2026 in Review

HeadInvest LLC reduced its Amgen (AMGN) stake by 2.5% in Q2 2026, selling an estimated $8.56K and leaving 971 shares worth $352K. The position accounts for 0.07% of the portfolio, ranked #174.

HeadInvest LLC first reported a position in AMGN in Q2 2013 and has held it in 8 quarters since. The position peaked at $660K in Q1 2014. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • HeadInvest LLC held 971 shares of Amgen worth $352K as of Q2 2026.
  • HeadInvest LLC sold 25 Amgen shares in Q2 2026, an estimated $8.56K.
  • Amgen made up 0.07% of HeadInvest LLC's portfolio in Q2 2026, its #174 holding.
  • HeadInvest LLC first reported a position in Amgen in Q2 2013 and has held it in 8 quarters since.
  • HeadInvest LLC's Amgen position peaked at $660K in Q1 2014.
  • 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on HeadInvest LLC's 13F filing for Q2 2026, filed 14 Aug 2026.